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Here we investigated the role of the amyloid precursor protein (APP) in regulation of Ca2+ store depletion-induced neural cell death. Ca2+ store
depletion from the endoplasmic reticulum (ER) was induced by the SERCA (Sarco/Endoplasmic Reticulum Calcium ATPase) inhibitor
thapsigargin which led to a rapid induction of the unfolded protein response (UPR) and a delayed activation of executioner caspases in the
cultures. Overexpression of APP potently enhanced cytosolic Ca2+ levels and cell death after ER Ca2+ store depletion in comparison to vector-
transfected controls. GeneChipR and RT-PCR analysis revealed that the expression of classical UPR chaperone genes was not altered by
overexpression of APP. Interestingly, the induction of the ER stress-responsive pro-apoptotic transcription factor CHOP was significantly
upregulated in APP-overexpressing cells in comparison to vector-transfected controls. Chelation of intracellular Ca2+ with BAPTA-AM revealed
that enhanced CHOP expression after store depletion occurred in a Ca2+-dependent manner in APP-overexpressing cells. Prevention of CHOP
induction by BAPTA-AM and by RNA interference was also able to abrogate the potentiating effect of APP on thapsigargin-induced apoptosis.
Application of the store-operated channel (SOC)-inhibitors SK & F96365 and 2-APB downmodulated APP-triggered potentiation of cytosolic
Ca2+ levels and apoptosis after treatment with thapsigargin. Our data demonstrate that APP significantly modulates Ca2+ store depletion-induced
cell death in a SOC- and CHOP-dependent manner, but independent of the UPR.
© 2006 Elsevier B.V. All rights reserved.Keywords: Alzheimer's disease; Apoptosis; Calcium store depletion; RNA interference; Microarray1. Introduction
The β-Amyloid Precursor Protein (APP) and its metabolism
play fundamental roles in the pathophysiology of familial and
sporadic Alzheimer's disease (AD) [1–3]. Aβ, the major
constituent of amyloid plaques in the brain of AD patients, is
generated by sequential β- and γ-secretase cleavage of APP inAbbreviations: AD, Alzheimer's disease; APP, amyloid precursor protein;
CHOP, C/EBP homologous protein-10; ER, endoplasmic reticulum; SERCA,
sarcoplasmic ER Ca2+-ATPase; UPR, unfolded protein response
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doi:10.1016/j.bbamcr.2006.10.002the amyloidogenic pathway [3–5]. This pathway is promoted by
mutations in APP, presenilin 1 and presenilin 2, and mutations
in these three genes associated with familial forms of AD (FAD)
[3,4,6]. In contrast, cleavage of APP within the Aβ domain
precludes formation of Aβ peptides in the anti-amyloidogenic
pathway. Although altered APP processing and aberrant
expression of APP are known to play a crucial roles in the
pathophysiology of AD and Down syndrome [4,7–11], much
less is known about the non-pathological, physiological
function of APP and its cleavage products [12]. However,
accumulating evidence suggests that APP is implicated in
regulation of gene expression [13–16].
Ca2+ is involved in a multitude of physiological functions in
neurons, such as neurotransmitter release and neuronal excit-
ability. On the other hand, intracellular Ca2+ overloading has
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evidence that dysregulation of Ca2+ homeostasis is critically
involved in brain aging [17] and the pathophysiology of AD
[18,19], and a contributory role of mutated presenilins and Aβ
for the disruption of Ca2+ homeostasis observed in AD has been
clearly established [2,18–20]. In addition to Aβ, further APP-
derived proteolytic cleavage products have been implicated in
disturbance of cellular Ca2+ homeostasis, including β-CTF
(C99), and the APP-intracellular domain (AICD), which
represent the C-terminal fragments of APP generated by β-
secretase and γ-secretase activities, respectively [18,21,22].
There is compelling evidence for an intimate association
between increased intracellular Ca2+ levels and the pathophy-
siological hallmarks of AD, i.e. a further accumulation of Aβ
peptides, hyperphosphorylation of Tau, and neuronal apoptosis
(reviewed in [22]).
The endoplasmic reticulum (ER) is considered to be the
major intracellular store of Ca2+ in neurons and non-neuronal
cells. The concentration gradients of Ca2+ in resting neurons
between the extracellular space (∼1–2 μM) and the cytoplasm
(50–300 nM), as well as between the cytoplasm and the ER
(100–500 μM) are steadily maintained by energy-dependent
Ca2+ transport systems: the plasma membrane Ca2+ ATPases
(PMCAs), and the sarcoplasmic/endoplasmic reticulum cal-
cium ATPases (SERCAs) [18,23]. Release of Ca2+ from the
lumen of the ER into the cytosol requires two types of ligand-
gated ion channels: the Inositol 1,4,5-trisphosphate (InsP3)
receptors (InsP3Rs) and the ryanodine receptors (RyRs) [20].
Another major pool of Ca2+ resides in the extracellular space.
Tight regulation of the influx of Ca2+ from the extracellular
space plays a critical role in maintaining neuronal Ca2+
homeostasis, both in resting neurons and after Ca2+ store
depletion. Acquisition of extracellular Ca2+ is achieved
through the activity of ligand-dependent Ca2+ channels,
voltage-dependent Ca2+ channels, and store-operated channels
(SOCs) [20,24].
A number of previous studies have suggested that dis-
turbances in Ca2+ homeostasis might play a crucial role in
sensitizing neurons to degeneration and cell death in AD
(reviewed in [2,18,20]). Since APP and its metabolism have
been implied in regulation of Ca2+ homeostasis, we investigated
the effect of overexpressed APP on the transcriptional stress
response and cell death after ER Ca2+ store depletion. Our data
reveal that overexpression of APP potentiates cytosolic Ca2+
levels after depletion of the ER stores by activating SOC-
dependent entry of Ca2+ from the extracellular space. Further-
more, we show that APP-dependent elevation of cytosolic Ca2+
levels is associated with enhanced expression levels of the pro-
apoptotic stress response gene CHOP, as well as CHOP-
dependent cell death after Ca2+ store depletion.2. Materials and methods
2.1. Materials
Thapsigargin was purchased from Alexis (Grünberg, Germany). Acetyl-
DEVD-7-amido-4-methylcoumarin (Ac-DEVD-AMC) was from Bachem(Heidelberg, Germany). All other biochemicals and chemicals came in
analytical grade purity from Roche Diagnostics (Mannheim, Germany) or
Roth (Karlsruhe, Germany). 5,5′-dimethyl BAPTA-AM (BAPTA-AM) was
from Molecular Probes (Invitrogen, Karlsruhe, Germany). The SOC
inhibitors 2-APB and SK & F96365 were from Sigma (Deisenhofen,
Germany).
2.2. Cell culture
PC12 cell lines expressing equal amounts of human wild type APP
(PC12 APPwt, clone M5), as well as vector-transfected control cells (PC12
vector, clone O1) have been described previously [25]. Cell lines were
cultivated in DMEM supplemented with 10% heat-inactivated fetal calf
serum, 5% horse serum, 100 U/ml penicillin and 100 μg/ml streptomycin.
All experiments were performed in NGF-untreated cells.
2.3. Calcium imaging
The cells were plated on poly-L-lysine-coated cover slips. Intracellular free
Ca2+ levels were quantified by fluorescence imaging of the calcium indicator
dye fura-2 as described previously [26]. Briefly, cells were incubated for
30 min in the presence of 5 μM acetoxymethylester form of fura-2 (Molecular
Probes, Amsterdam, The Netherlands), then washed twice with HBSS buffer
and incubated for 30 min prior to imaging. Cells were imaged on a Zeiss
Axiovert microscope (40× oil immersion objective) coupled to an Attofluor
imaging system. The average Ca2+ concentration in 12–20 cell bodies per
microscope field was quantified in 8–12 independent experiments (from at
least four separate cultures) per treatment condition. Fluorescence was
monitored prior to (baseline calcium) and after exposure of cells to vehicle
or thapsigargin (1 μM; peak calcium) which were added to the bathing medium
by dilution from a 2× stock. DMSO vehicle treatment did not alter basal
fluorescence of fura-2. Fluorescence was quantified using the fluorescence
ratio (R) of the emission (510 nm) measured following excitation at 340 nm
divided by the emission following excitation at 380 nm.
2.4. Quantification of apoptosis
Measurement of caspase 3-like protease activity and analysis of nuclear
apoptosis was performed as described previously [14].
2.5. Western blotting
Western blotting was essentially performed as described previously [14].
The blots were incubated with a mouse monoclonal anti-CHOP antibody
(Santa Cruz Biotechnology, Heidelberg, Germany) diluted 1:1.000, a mouse
monoclonal anti-GAPDH antibody (Acris, Hiddenhausen, Germany) diluted
1:10.000, a rabbit polyclonal anti-active p20 caspase 7 antiserum (New
England Biolabs, Frankfurt, Germany) diluted 1:1000 or a rabbit polyclonal
anti-active p20 caspase 3 antiserum (Merck-Frosst, Kirkland, Canada) diluted
1:1.000. To ensure equal loading of the samples, membranes were incubated
with a mouse monoclonal anti-α-Tubulin antibody (clone DM 1 A; Sigma,
Deisenhofen, Germany) diluted 1:10.000.
2.6. Semiquantitative RT-PCR
Semiquantitative RT-PCR and quantification of CHOP, BiP and GAPDH
expression was performed as described previously [25].
2.7. Microarray analysis
Generation of cRNA probes and hybridization to RG-U34A arrays
(Affymetrix) was performed as described elsewhere [25]. The Affymetrix
Microarray Suite 5.0 was used to scan and analyze the relative abundance of
each gene from the average difference of intensities. For each individual
gene, the signal ratio between perfect match and mismatch probe cells was
used to determine its “Absolute Call”, indicating whether the corresponding
transcript was present (P), absent (A), or marginal (M). For analysis of
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was employed. Individual transcript levels were ranked as either increased
(I), marginally increased (MI), decreased (D), marginally decreased (MD) or
not changed (NC). To be considered as differentially upregulated, the
Absolute Call of individual transcripts had to be present, the Difference Call
increased, and the fold induction had to be at least 3.0 fold in PC12 vector
control cells.
2.8. Knockdown of CHOP
Annealed double-stranded siRNAs were obtained from Ambion (Hunting-
don, United Kingdom). The sequence of the CHOP siRNA was follows: 5′-
GGUCCUGUCCUCAGAUGAAdTdT-3′ (sense) and 5′-UUCAUCUGAG-
GACAGGACCdTdG-3′. Blast searches confirmed that these sequences were
not homologous to any genes other than CHOP in rats. Cells were transfected
with 30 nM siRNAs using siMPORTER™ (Biomol, Hamburg, Germany) or
mock-transfected as described by the manufacturer. After incubation of the
transfected cells for 20 h, they were treated with thapsigargin or vehicle
(DMSO).
2.9. Statistics
Data are given as means±SEM. For statistical comparison, t-test or
one-way ANOVA followed by Tukey test were employed. P values smaller
than 0.05 were considered statistically significant.Fig. 1. Overexpression of wild type APP enhances thapsigargin-induced cytoplasm
activation. Cultures of PC12 neo O1 (vector) and PC12 APPwtM5 (APP) cells were t
Caspase 3-like activity was monitored over 1 h. Data are means±SEM from n=4 to
results. A.U.=arbitrary fluorescence units. *p<0.05: Difference from vehicle-treated
Activation of caspase 7 during thapsigargin-induced apoptosis. PC12 neo O1 (vector)
vehicle (Con) for 16 h. Active caspase 7 p20 subunits were detected by Western Blot
times with similar results. (C) Nuclear apoptosis visualized by Hoechst staining. Cultu
1 μM thapsigargin (Tha) or vehicle (Con) for 20 h. Scale bar: 25 μm. (D) Quantitative
repeated two times with similar results. *p<0.05: Difference from vehicle-treated cont
Analysis of cytoplasmic Ca2+ levels after store depletion with thapsigargin by fura-2
treatedwith 1 μM thapsigargin or vehicle (DMSO). Absolute cytoplasmic Ca2+ levels (
with thapsigargin; *p<0.05 vs. untreated control (PC12 vector). The difference of cyto
after store depletion (nmol/l) obtained from the experiment shown in panel E are sho3. Results
3.1. ER store depletion by thapsigargin leads to enhanced
cytoplasmic Ca2+ levels and apoptosis in APP overexpressing
cells
To analyze the role of APP as a modulator of Ca2+
homeostasis and Ca2+ store depletion-induced cell death, we
employed rat PC12 cell lines overexpressing the wild type
human APP695 isoform (PC12 APP) in comparison with the
empty vector-transfected control cell line PC12 vector (PC12
vector)[25]. Of note, we have previously shown that over-
expression of membrane proteins transported via the ER/Golgi
secretory pathway per se does not affect the sensitivity of
PC12 cells to apoptosis [25]. In initial experiments, we
established the optimal working concentrations and incubation
periods for activation of effector caspases after Ca2+ store
depletion induced by thapsigargin in parental PC12 cells (data
not shown). Overexpression of APP was associated with
significantly enhanced effector caspase activity 20 h after
treatment with 0.3 μM and 1 μM thapsigargin (Fig. 1A).ic Ca2+ levels and apoptosis in PC12 cells. (A) Analysis of effector caspase
reated with the indicated concentrations of thapsigargin or vehicle (Con) for 20 h.
6 cultures per treatment. The experiment was repeated two times with similar
controls. vp<0.05: Difference from respective control cell line PC12 vector. (B)
and PC12 APPwtM5 (APP) cells were treated with 0.3 μM thapsigargin (Tha) or
ting with α-tubulin serving as a loading control. Experiments were repeated two
res of PC12 neo O1 (vector) and PC12 APPwt M5 (APP) cells were treated with
analysis of nuclear apoptosis visualized by Hoechst staining. Experiments were
rols.vp<0.05: Difference from respective control cell line PC12 vector. (E and F)
Calcium Imaging. PC12 neo O1 (vector) and PC12 APPwt M5 (APP) cells were
nmol/l) are shown in panel E. Data represent peaks of Ca2+ levels after stimulation
plasmicCa2+ levels in comparison to the DMSOcontrol in the respective cell lines
wn in panel F. *p<0.05 vs. control (PC12 vector).
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gargin-induced activation of effector caspase 7 was more
prominent in the APP-overexpressing cell line in comparison
to the PC12 vector control (Fig. 1B). Next, we visualized
nuclear apoptosis in PC12 vector and PC12 APP cells by
Hoechst staining on the single-cell level. Cultures of APP-
overexpressing cells revealed an increased incidence of cells
displaying an apoptotic nuclear morphology after treatment
with 0.3 μM thapsigargin (Fig. 1C). Subsequent quantitative
analysis by counting the number of apoptotic nuclei in the
cultures revealed that the percentage of apoptotic cells in the
thapsigargin-treated PC12 APP cultures was markedly higher
than PC12 vector control cells (Fig. 1D). Analysis of APP-
mediated effects on cytoplasmic [Ca(2+)] after depletion of the
ER Ca2+ stores with thapsigargin was performed by Fura2-
Imaging (Fig. 1E and F). While there were no significant
changes in the baseline values of cytoplasmic [Ca(2+)] in
vehicle-treated PC12 APP cells (Fig. 1E), overexpression ofFig. 2. APP regulates transcriptional events in response to ER Ca2+ store depletion. (
thapsigargin. PC12 neo O1 (vector) and PC12 APPwt M5 (APP) cells were treated w
8 h. cRNAwas prepared and hybridized to Rat-U34A microarrays (Affymetrix) afte
Suite 5.0 software (MAS 5.0) as described in Materials and methods. Genes found
shown with fold-induction values (as determined with MAS 5.0) in comparison to the
CHOP expression is enhanced by APP. For analysis of CHOP and BiP expression, cD
vehicle (con) or 0.3 μM thapsigargin for 1 h, 2 h and 4 h and 8 h was amplified by 25
products were separated by agarose gel electrophoresis and visualized with 0.1% eth
analyzed with the OneDScan software, and are shown as fold induction value relativ
n=4 cultures per treatment. *p<0.05 vs. control (PC12 vector DMSO).APP significantly enhanced cytoplasmic [Ca(2+)] transients
after treatment with thapsigargin (Fig. 1E and F).
3.2. APP modulates the transcriptional stress response to
thapsigargin
Many ER resident chaperones require high ER Ca2+
concentrations for their activity. Thus, ER Ca2+ store depletion
leads to accumulation of misfolded proteins in the ER, a
condition known as ER stress. ER stress activates a conserved
cellular stress response, the so called unfolded protein response
(UPR). Thapsigargin has been shown to activate the unfolded
protein response (UPR) [27] and our data clearly demonstrated
that APP significantly enhances cell death induced by ER Ca2+
store depletion. To investigate the underlying transcriptional
mechanisms of APP-mediated cell death potentiation, we
performed gene expression microarray analysis of APP-
mediated transcriptional changes in APP-overexpressing cells.A) Expression profiling by microarray analysis after induction of ER stress with
ith 0.3 μM thapsigargin for 8 h. Controls were treated with vehicle (DMSO) for
r which relative mRNA levels were quantified with the Affymetrix Microarray
to be differentially expressed in both cell lines after thapsigargin-treatment are
control (PC12 vector DMSO). (B and C) Thapsigargin-induced upregulation of
NA from PC12 neo O1 (vector) and PC12 APPwt M5 (APP) cells treated with
cycles of PCR with GAPDH serving as internal control. (C) PCR amplification
idium bromide. (B) Band intensities relative to the GAPDH control bands were
e to the control (PC12 vector treated with vehicle). Data are means±SEM from
Fig. 3. Buffering of cytosolic Ca2+ with BAPTA-AM antagonizes the
potentiating effect of APP on CHOP expression and cell death. PC12 vector
(vector) and PC12 APP (APP) cells were treated with 1 μM thapsigargin in the
presence or absence of 1 μM BAPTA-AM for 12 h. Controls were treated with
vehicle (DMSO) in the presence or absence of BAPTA-AM (1 μM) for 12 h. (A)
Protein expression levels of CHOP after treatment with 1 μM BAPTA-AM and
treatment with 1 μM thapsigargin was analyzed by Western blotting with alpha-
Tubulin expression levels serving as a loading control. Experiments were
performed three times with similar results. (B) Analysis of effector caspase
activation after thapsigargin treatment. Caspase 3-like activity was monitored
over 1 h. Data are means±SEM from n=4 cultures per treatment. A.U.=
arbitrary fluorescence units. Experiments were performed three times with
similar results. *p<0.05 vs. untreated control (PC12 vector); vp<0.05:
difference from respective control cell line PC12 vector. n.s.: not significant.
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ER stress with thapsigargin revealed that several UPR target
genes were significantly upregulated in both PC12 vector and
PC12 APP cells. In comparison to the PC12 vector control,
most UPR target genes implicated in alleviation of ER stress
(molecular chaperones such as BiP, grp94, Erp70 and calnexin)
were induced to a comparable extent in PC12 APP cells (Fig.
2A). However, expression of serum/glucocorticoid-regulated
kinase 1 (sgk1), the stress-responsive pro-apoptotic kinase
NIPK and the pro-apoptotic transcription factor CHOP, was
notably enhanced by overexpression of APP. Transcriptional
induction of BiP and CHOP was also analyzed by semiquanti-
tative RT-PCR after treatment with 0.3 μM thapsigargin for 1, 2
and 4 h (Fig. 2B and C). The kinetics and magnitude of BiP
induction were very similar for both cell lines (PC12 vector O1
and PC12 APPwt M5). As predicted from the microarray data,
RT-PCR analysis of the kinetics of CHOP induction revealed
that thapsigargin elicited an increased expression of the CHOP
gene in PC12 APP cells (Fig. 2B and C).
3.3. Chelation of intracellular Ca2+ with BAPTA-AM
downmodulates CHOP induction and Ca2+ store
depletion-induced cell death
In light of the facts that expression of CHOP has been
suggested to be induced by activation of the UPR [28], but
also by enhanced cytosolic Ca2+ levels [29], we next analyzed
the effect of the Ca2+ chelator BAPTA-AM on the observed
potentiation of thapsigargin-triggered CHOP induction in
PC12 APP cells (Fig. 3A). Indeed, treatment with BAPTA-
AM lead to a prominent downmodulation of CHOP induction
in PC12 APP cells, whereas the effect of BAPTA-AM on
CHOP expression in PC12 vector cells was less pronounced
(Fig. 3A). To correlate these observations with APP-dependent
modulation of apoptosis, we again performed DEVDase
assays (Fig. 3B). Interestingly, chelation of intracellular Ca2+
with BAPTA-AM was able to downmodulate apoptosis in
PC12 APP cells to a level comparable to that observed in
PC12 vector cells (Fig. 3B).
3.4. RNA interference against CHOP abrogates the potentiating
effect of APP on Ca2+ store depletion-induced cell death
Our data obtained so far suggested that APP significantly
modulated CHOP expression and cell death after Ca2+ store dep-
letion. To investigate the functional relevance of CHOP in the
potentiating effect of APP on cell death triggered by Ca2+ store
depletion, we knocked down expression of CHOP by siRNA. To
monitor the silencing of CHOP we performed Western blot
analysis after treatment with 1 μM Thapsigargin (Fig. 4A). In
comparison to mock-transfected cultures, the thapsigargin-induced
CHOP protein levels were significantly lowered by application of
CHOP siRNA in both PC12 vector and PC12 APP cultures (Fig.
4A). Subsequent DEVDase assays revealed that silencing of
CHOPmarkedly reduced thapsigargin-triggered apoptosis in PC12
APP to a level comparable to that observed in PC12 vector cells
after Ca2+ store depletion (Fig. 4B).3.5. Inhibition of store-operated channels (SOCs)
downmodulates APP-dependent potentiation of cytoplasmic
Ca2+ levels and apoptosis after ER store depletion
Our initial Ca2+ imaging experiments in PC12 APP cells
clearly demonstrated abnormally high intracellular Ca2+ levels
after store depletion (Fig. 1E and F). On the one hand, these data
might reflect elevated ER Ca2+ levels in untreated PC12 APP
cells in comparison to PC12 vector control cells, leading to an
increased release of ERCa2+ into the cytosol after store depletion
with thapsigargin. On the other hand, store depletion is also
known to activate the influx of extracellular Ca2+ through SOCs,
and this influx might be affected by overexpressed APP. To
discriminate between these two possibilities, we next investi-
gated a possible amplifying effect of APP on SOC entry of Ca2+.
To this end, we applied two different SOC-inhibitors, 1-{beta-[3-
(4-methoxyphenyl)propoxyl]-4-methoxyphenethyl}-1H-imida-
zole (SK & F96365) and 2-Aminoethoxydiphenyl borate (2-
APB). To prevent potential non-selective effects of these
inhibitors on the Ca2+ release from the ER [30,31], we used
both inhibitors at a final concentration of 10 μM. Fura2-Imaging
again revealed potently enhanced cytoplasmic [Ca(2+)] transients
after treatment with thapsigargin in PC12 APP cells (Fig. 5A–C).
Fig. 4. Knockdown of CHOP with siRNA abrogates potentiation of Ca2+ store
depletion-induced cell death in PC12 APP cells. Cultures of PC12 neo O1
(vector) and PC12 APPwt M5 (APP) cells were mock-transfected or transfected
with 30 nM of CHOP siRNA, incubated for 16 h, and then treated with 1 μM
thapsigargin (Tha) or vehicle (Con) for 12 h. (A) Protein expression levels of
CHOP after treatment with CHOP siRNA and subsequent treatment with 1 μM
thapsigargin was analyzed by Western blotting. GAPDH expression levels
served as a loading control. Experiments were performed three times with
similar results. (B) Analysis of effector caspase activation after thapsigargin
treatment. Caspase 3-like activity was monitored over 1 h. Data are means±
SEM from n=4 cultures per treatment. A.U.=arbitrary fluorescence units.
Experiments were performed three times with similar results. *p<0.05 vs.
untreated control (PC12 vector); vp<0.05: difference from respective control
cell line PC12 vector. n.s.: not significant.
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(Fig. 5A and B), as well as 2-APB (Fig. 5A and C) on
cytoplasmic Ca2+ transients after store depletion in both cell
lines, which however was much more potent in PC12 APP cells
compared to PC12 vector cells (Fig. 5A–C). Indeed, the
cytoplasmic [Ca(2+)] transients in the presence of both SOC-
inhibitors (reflecting the ER Ca2+ release) reached very similarFig. 5. APP potentiates SOC entry of Ca2+ after ER store depletion. (A) Analysis of cy
depletion in the presence or absence of the SOC inhibitors SK & F96365 and 2-APB
F96365 and 30 μM 2-APB prior to stimulation with 1 μM thapsigargin. Representativ
(A, right panel) treated solely with thapsigargin (black curves) are shown in compariso
curves) and 2-APB (light grey curves), respectively. (B and C) SOC inhibitors signifi
and C, left panels). Quantitative differences of thapsigargin-induced cytoplasmic Ca2+ l
panel) in PC12 vector and PC12APP cells are shown in relation to the baseline values (
Ca2+ levels after stimulation with thapsigargin;vp<0.05: Difference from respective
SOC inhibitors abrogate the potentiating effect of APP on intracellular Ca2+ levels a
between cytoplasmic Ca2+ levels (nmol/l) after treatment with thapsigargin +/− SK&F
and PC12APP cells, respectively. *p<0,05: Difference from control cell line PC12 vec
vector (vector) and PC12 APP (APP) cells were preincubated with 5 μMBAPTA-AM
absence of 10 μMSK&F96365 (left panel) or 10 μM2-APB (right panel) for 12 h. Co
or 2-APB and BAPTA-AM for 12 h. Caspase 3-like activity was monitored over
fluorescence units. *p<0.05 vs. untreated control (PC12 vector); vp<0.05: differenclevels in PC12 APP and PC12 neo cells, indicating that APP-
dependent Ca2+ overloading after store depletion occurred via
amplified SOC entry of Ca2+. We also investigated the effect of
SOC-inhibition on thapsigargin-triggered apoptosis (Fig. 5D).
Apoptosis was most potently inhibited after co-application of
SK & F96365 and 2-APB with BAPTA-AM (Fig. 5D),
indicating that Ca2+ release from the ER and SOC entry of
Ca2+ act in a synergistic manner to promote apoptosis after
treatment with thapsigargin. SK & F96365 and 2-APB alone
were also able to significantly decrease the potentiating effect
of APP on thapsigargin-triggered apoptosis (Fig. 5D), whereas
the inhibitory effect on apoptosis in PC12 vector control cells
was less pronounced (Fig. 5B).
4. Discussion
In this study, we investigated the effect of overexpressed
APP on ER Ca2+ store depletion-induced apoptosis in rat PC12
cells. Interestingly, our data show that APP potentiates both
cytoplasmic Ca2+ levels and subsequent apoptosis after store
depletion. Since this potentiation could be completely abolished
by the application of the two SOC inhibitors SK & F96365 and
2-APB, our data suggest that enhanced cytoplasmic Ca2+
transients and amplification of store depletion-triggered cell
death by APP are probably not caused by ER Ca2+ overloading,
but rather by an APP-dependent amplification of SOC entry of
Ca2+ after store depletion. Interestingly, it has been proposed
that full length APP might function as a cell surface receptor
[32,33], thus providing the theoretical possibility for a
cooperative interaction between APP and SOCCs in the cell
membrane.
Subsequent analysis of the underlying transcriptional me-
chanisms of APP-mediated cell death potentiation bymicroarray
analysis indicated that APP is capable of regulating transcrip-
tional events in response to ER Ca2+ store depletion. Since many
ER resident chaperones require high ER Ca2+ concentrations for
their activity, ER Ca2+ store depletion leads to accumulation of
misfolded proteins in the ER and activation of the unfolded
protein response (UPR) [34,35]. Our GeneChip analysis of
transcriptional changes after induction of ER stress with
thapsigargin revealed that many UPR target genes were signi-
ficantly upregulated in both PC12 vector and PC12 APP cells. In
comparison to the PC12 vector control, most UPR target genestosolic calcium levels by fura-2 calcium imaging after thapsigargin-induced store
. PC12 vector and PC12 APP cells were incubated for 120 s with 10 μM SK &
e fura-2 ratio time traces of PC12 vector cells (A, left panel) and PC12 APP cells
n to PC12 vector and PC12APP cultures pretreated with SK&F96365 (dark grey
cantly downmodulate cytoplasmic Ca2+ transients in response to thapsigargin (B
evels in the presence or absence of SK & F96365 (B, left panel) or 2-APB (C, left
prior to any treatment) of the respective cell lines (nmol/l). Data represent peaks of
cell line in the absence of SK & F96365 (B, left panel) and 2-APB (C, left panel).
fter store depletion (B and C, right panels). Data are indicated as the difference
96365 (B, right panel), or thapsigargin +/− 2-APB (C, right panel) in PC12 vector
tor. (D) Analysis of effector caspase activation after thapsigargin treatment. PC12
or vehicle for 30 min and then treated with 1 μM thapsigargin in the presence or
ntrols were treated with vehicle (DMSO) in the presence or absence SK&F96365
1 h. Data are means±SEM from n=3 cultures per treatment. A.U.=arbitrary
e from respective control cell line PC12 vector. n.s.: not significant.
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such as BiP, grp58, grp94, Erp70, calreticulin and calnexin) were
induced to a comparable extent in PC12 APP cells.
In contrast to chaperones, expression of the stress-responsive
pro-apoptotic kinase NIPK [36] and the transcription factor
CHOP [28,37] was notably enhanced by overexpressed APP.
RT-PCR analysis of the kinetics of CHOP expression confirmed
that thapsigargin elicited an enhanced induction of the CHOP
gene in PC12 APP cells. Interestingly, both CHOP and NIPKare downstream targets of the transcription factor ATF4 [36,38].
However, NIPK may not be directly activated by ATF4, since it
has been described as a downstream target of CHOP in a recent
study [39]. CHOP is ubiquitously expressed and exerts pro-
apoptotic effects in various cell types. However, there is
compelling evidence that CHOP plays a particular role in
regulation of neuronal apoptosis in acute and chronic CNS
diseases, including Alzheimer's disease [28,40]. It has been
shown that CHOP mRNA stability is significantly increased in
164 E. Copanaki et al. / Biochimica et Biophysica Acta 1773 (2007) 157–165the presence of elevated cytoplasmic Ca2+ levels [29],
suggesting that the potentiation of CHOP expression observed
in PC12 APP cells might occur on the posttranscriptional level.
Interestingly, our data reveal that buffering of cytosolic Ca2+
with BAPTA-AM was able to downmodulate APP-dependent
potentiation of CHOP expression and cell death. In line with
these observations, transcriptional upregulation of CHOP after
treatment with the Ca2+ ionophore A23187 was also inhibitable
by BAPTA-AM [29]. In contrast to the effect of Ca2+ chelation
on CHOP expression, BAPTA-AM has been shown to have no
inhibitory effect on thapsigargin-triggered expression of the ER
chaperone Erp72 [41]. Collectively, these observations suggest
that increases in cytosolic Ca2+ levels selectively enhance
CHOP expression in a UPR-independent manner after Ca2+
store depletion with thapsigargin. From these data we conclude
that APP-mediated potentiation of CHOP expression reflects a
cumulative effect of increased cytosolic Ca2+ levels and
induction of ER stress after ER store depletion. Further evidence
for this hypothesis is provided by the fact that APP over-
expression is not associated with transcriptional alterations in
CHOP expression after induction of ER stress with tunicamycin,
an ER stressor that does not affect ER Ca2+ levels [25].
Interestingly, silencing of CHOP expression by RNA inter-
ference was capable of completely abolishing the potentiating
effect of APP on apoptosis triggered by Ca2+ store depletion,
emphasizing the fundamental role of CHOP in this type of stress-
induced, Ca2+-dependent cell death. Our data indicate that by
amplification of Ca2+ entry through SOCCs, overexpressed APP
potentiates cytoplasmic Ca2+ levels and subsequent CHOP
expression, culminating in enhanced cell death after Ca2+ store
depletion.
Overexpression of wild type APP in neural cells has been
previously shown to either diminish or enhance cell death by
various apoptotic triggers, suggesting that APP affects the
cellular sensitivity to apoptosis in a stimulus-specific manner
[14,25,42,43]. Since overexpression of APP has been impli-
cated in AD and Down syndrome [7–11], the amplified APP-
dependent SOC entry of Ca2+ observed in this study might
selectively sensitize neurons to insults triggering pathophysio-
logical store depletion. Of note, our data suggest that CHOP
seems to play a role only in the presence of high Ca2+ levels,
since a potent downmodulating effect of CHOP siRNA could be
observed only in thapsigargin-treated PC12 APP cells, but not
in PC12 vector cells. Thus, Ca2+ levels enhanced by APP might
induce CHOP-dependent apoptosis both on the transcriptional
and post-transcriptional level after store depletion.
In conclusion, this study establishes that by potentiating
SOC entry of Ca2+, overexpression of APP triggers enhanced
expression levels of the death-promoting gene CHOP and
potently increases neuronal apoptosis after Ca2+ store depletion.
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